Dry Powder Inhalers: Annual Conference

Event

In Le Meridien Piccadilly, London

£ 1,399 + VAT

Description

  • Type

    Event

  • Level

    Intermediate

  • Location

    Le meridien piccadilly, ...

  • Duration

    2 Days

The second generation of DPIs have become either established on the market or are a signi cant way along the approval process, these have been a great success story in improving inhaled drug delivery. However, we now have to tackle the technical and regulatory issues with ‘generic’ inhalers and their approval. The development of triple therapies is well underway, these bring about their own challenges of formulation and bioequivalence. Amazingly, new DPIs are still being created, with some moving in to development programs. Further, one of the areas where much study and recent guidance has been applied is in considering the patient use, compliance and human factors associated with DPIs. These linked topics are creating a whole new area that requires better understanding during product development and associated studies.
This conference aims to: address many of the issues around generic inhalers, provide case studies of bioequivalence testing, focus on the dif cult formulation challenges and the strategies used so that they may be overcome and to discuss in-depth patient and human factor issues when developing a DPI to gain regulatory approval.

Facilities

Location

Start date

Le Meridien Piccadilly, London (London)
See map

Start date

On request

About this course

How to develop a generic DPI: from scratch to market
Designing drugs for inhalation – achieving solutions
How much does it cost to develop a generic DPI inhaler?
Easyhaler device and performance under simulated real-life conditions
Clinical Bioequivalence of OT329 Solis and ADVAIR DISKUS
Asthma UK’s 2016 Annual Report
The AOS add-on device as a novel tool to improve powder dispersion
Parameters in uencing the performance of interactive blends for inhalation
Challenges of industrialisation of a novel user friendly DPI
Case study: comparing usability of two inhalers with the same drug but differen

Those involved in
Respiratory drug development
Inhalation product development
Device engineering
Formulation Development
Scientific research
Medical marketing
Marketing and Business development

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

Subjects

  • Market
  • Inhalers
  • Medical Devices
  • Training
  • Management
  • Pharma
  • Pharmaceutical Marketing
  • Intellectual Property
  • Legal
  • Medical

Teachers and trainers (2)

Dr Steve Nichols

Dr Steve Nichols

Director, OINDP Consultancy, UK

Mike Holroyd

Mike Holroyd

Senior Director, Mylan, UK

Course programme

Key Annual Conference for Pharmaceutical and Medical Device Professionals in the DPI Market

THREE REASONS TO ATTEND

  1. Key annual gathering for pharmaceutical and medical device professionals in the DPI market
  2. Keep abreast of what’s happening in formulation, biologics, generics and emerging markets
  3. Technology showcase highlighting new devices

Additional information

Credits/Points: 5.5 CPD Hours Per Day

Dry Powder Inhalers: Annual Conference

£ 1,399 + VAT